secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENEREX PHARMA, INC. (RGPX)
CIK:        0001357878
Form:       8-K
Filed at:   2021-11-18T23:59:59+00:00
Accession:  0001472375-21-000133
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Peptide Technologies acquires wound healing IP for 150M shares and $10M deferred cash
--------------------------------------------------------------------------------

- Acquired Wound Healing Technology Platform from Gregory P. Pilant and Deborah L. Pilant for 150M restricted common shares and $10M deferred cash.
- Cash payment of $10M to be funded from future revenue or investment, due within 60 months, with no interest.
- Closing deadline set for November 25, 2021 (within 10 days of signing on November 15, 2021).
- Technology platform includes drug candidates and biological solutions for chronic wound care in humans.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357878/000147237521000133/0001472375-21-000133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357878/000147237521000133/ixform8k.htm
  HTML page:      https://secwatch.observer/filing/0001472375-21-000133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer